In short. Tissue rebuilding, reversal of ageing and the survival of injected cells are asserted far more often than they are measured.
Key points
- Safety data come from products that are defined, tracked and reported on.
- A product sold outside approval has none of that structure, so harm that occurs may never be recorded anywhere.
- The absence of reported harm in that situation tells you about the reporting rather than about the product.
Claims in this category fail in a consistent way: each takes something that is plausible, or that happens in a laboratory, and states it as something that happens in a person. Listing them makes the boundary visible.
That tissue is rebuilt
Rebuilding requires cells to survive, to take on a function, to integrate and to persist. Injected cells generally do not survive in useful numbers, so most of what is described as rebuilding has to be explained by a signal rather than by the presence of the cells. That may still be an effect, and it is not the effect the word describes, and the difference is not a matter of emphasis.
That ageing is reversed
No approved claim describes a reversal of ageing. The phrase names an aspiration and it is used as though it named an outcome, and the two are difficult to separate once the sentence is written. Where a specific change is claimed, the questions that make it checkable are what was measured, over how long, and against what comparison.
An absence of reporting is not a finding of safety
Safety data come from products that are defined, tracked and reported on. A product sold outside approval has none of that structure, so harm that occurs may never be recorded anywhere. The absence of reported harm in that situation tells you about the reporting rather than about the product.
That newer products are safer
A product in use for a shorter time has a shorter safety record. That is the opposite of reassurance, and there is no comparative data supporting the claim that newer materials in this group are safer than older ones. Newness is a manufacturing fact and it is used here as though it were a finding.
That a mechanism establishes an effect
The mechanism is where the reasoning begins. It is presented as though it were where the reasoning ended, and in this category it usually has, because the studies that would continue it are long, expensive and not required of a product sold outside approval.
That the category carries a grade
It does not. The materials grouped under the word have very different evidence behind them, from approved uses at one end to nothing at all at the other. A statement about regenerative treatments is a statement about an average of unrelated things, and it is true of none of them.
Three claims that do not hold
- It rebuilds your own tissue — when injected cells generally do not survive to do the rebuilding.
- It reverses ageing — when no approved claim describes a reversal of anything.
- It is safer because it is newer — when newness means a shorter record, not a better one.
Refusing these claims leaves the established facts standing: a few materials approved for named uses, a blood-derived preparation with mixed evidence, and a group of products that are generally not approved at all.
Frequently asked questions
Do injected cells stay where they are placed?
Most do not survive in useful numbers. This is a general finding in cell-based treatment rather than a criticism of one product, and it matters because a treatment described as rebuilding tissue requires the cells to be present to do the rebuilding. Without survival, the claim has to be restated as a claim about a transient signal.
Is any regenerative treatment shown to reverse ageing?
No. No approved claim describes a reversal of ageing, and the phrase describes an aspiration rather than a measurable outcome. Where a change is claimed, the useful questions are what was measured, over how long and against what comparison, and the answers are usually thinner than the sentence.
Does an absence of reported harm mean a product is safe?
It does not. A product sold outside approval is not tracked, so harm that occurs may never be recorded anywhere. An absence of reported harm in that situation is an absence of reporting, which is a different thing from a finding of safety.
Risks & Limitations
- The word regenerative describes a marketing position rather than an approved class, and no authority approves a material as regenerative.
- Cell and exosome products are generally not approved as cosmetic treatments, and warnings have been issued about advertising them as treatments.
- Most injected cells do not survive in useful numbers, which is the step that a claim of tissue rebuilding depends on.
- An absence of reported harm in an unapproved product is an absence of reporting rather than a finding of safety.
- A point-of-care preparation carries a risk of infection introduced during preparation, because blood handled outside a controlled laboratory is a medium in which bacteria grow.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after a procedure.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- Any new and persistent symptom after a procedure, or a change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — warnings and guidance on unapproved cell and exosome products
- European Medicines Agency (EMA) and national regulators — advanced therapy classification and guidance
- National Medical Products Administration (NMPA, China) — approved biological products and their indications
- World Health Organization (WHO) — guidance on cell and tissue-based therapies and their oversight
- Cochrane Library — systematic reviews of cell-based and platelet treatments for skin indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.